China Universal Asset Management Co., Ltd. Inhibrx, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$32.76 - $39.56 $119,082 - $143,800	3,635 Added 66.44%	9,106 $318,000
Q4 2023 May 21, 2024	SELL	$14.5 - $38.0 $52,707 - $138,130	-3,635 Reduced 39.92%	5,471 $207,000
Q4 2023 Jan 23, 2024	BUY	$14.5 - $38.0 $63,133 - $165,452	4,354 Added 389.79%	5,471 $208,000
Q3 2023 May 21, 2024	BUY	$15.75 - $26.31 $8,583 - $14,338	545 Added 95.28%	1,117 $20,000
Q3 2023 Oct 30, 2023	BUY	$15.75 - $26.31 $8,583 - $14,338	545 Added 95.28%	1,117 $20,000
Q2 2023 May 21, 2024	SELL	$16.96 - $27.82 $305 - $500	-18 Reduced 3.05%	572 $14,000
Q2 2023 Jul 27, 2023	SELL	$16.96 - $27.82 $305 - $500	-18 Reduced 3.05%	572 $15,000
Q1 2023 May 21, 2024	BUY	$18.45 - $27.14 $2,730 - $4,016	148 Added 33.48%	590 $11,000
Q1 2023 Apr 27, 2023	BUY	$18.45 - $27.14 $2,730 - $4,016	148 Added 33.48%	590 $11,000
Q4 2022 May 21, 2024	SELL	$20.18 - $33.33 $174,839 - $288,771	-8,664 Reduced 95.15%	442 $10,000
Q4 2022 Jan 31, 2023	BUY	$20.18 - $33.33 $1,553 - $2,566	77 Added 21.1%	442 $11,000
Q3 2022 Oct 21, 2022	BUY	$11.58 - $24.73 $4,226 - $9,026	365 New	365 $7,000

Others Institutions Holding INBX

# of Institutions

Shares Held

25.3K

Call Options Held

Put Options Held

View Full List

About Inhibrx, Inc.

Ticker INBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,057,700
Market Cap $617M
Description
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...

More about INBX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account